Business
If only Ellume was an ASX share! Why it’s making big news today
For an unlisted company, Ellume certainly knows how to keep ASX investors talking. The Brisbane-based health company also made news last year. This was due to its announcement that the United States Food and Drug Administration (FDA) had endorsed one of its products.
As we discussed at the time, Ellume specialises in rapid diagnostic technology. The company had developed a rapid test for the COVID-19 infection. The test only costs around US$30. It can reportedly detect traces of coronavirus in as little as 15 minutes with a 94% sensitivity in detecting infection.
Following that endorsement from the FDA, Ellume ramped up plans to send more than 100,000 of its tests to the US. At the time, Ellume planned on delivering more than 5…
-
Business23 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News24 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage
-
Noosa News24 hours agoPolice search Bli Bli property as homicide team called in for missing Brisbane man
-
Business20 hours agoDoes Macquarie rate Rio Tinto shares a buy, hold or sell after its big news?